Pure Global
NCT04450745

Physical Exercise in Normobaric Hypoxia and Normoxia in Type 1 Diabetic Patients

Silesian Centre for Heart Diseases·ClinicalTrials.gov·behavioralEnrolling by invitation
View on ClinicalTrials.gov →
Study focus
Disease/Condition
type1diabetes
Drug/Device/Intervention
Exercise in hypoxia
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Silesian Centre for Heart Diseases
Location
Zabrze, Poland
Timeline & enrollment
Phase
N/A
Start date
Oct 30, 2019
End date
Sep 30, 2020
Enrollment
16 participants
Primary outcome

Maximum oxygen consumption (VO2max),Metabolic control of diabetes,Glucose stability

Summary

Physical activity, along with proper nutrition, is the basis for the behavioral treatment of
 diabetes. In recent years exercise training in normobaric hypoxia is used in training
 programs for athletes and in rehabilitation. The aim of this study is the assessment of
 physical exercise in normobaric hypoxia condition on metabolic control of diabetes: blood
 glucose profile, its stability, HbA1c value, hypoglycemia: frequency, level, severity and
 time of occurrence, insulin demand, maximal muscle strength level, VO2max and anthropometric
 parameters.

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04450745
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04450745 through Pure Global AI's free database. This phase not specified trial is sponsored by Silesian Centre for Heart Diseases and is currently Enrolling by invitation. The study focuses on type1diabetes. Target enrollment is 16 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.